Table 1. Patient information.
| Group | Ref# | Age | Sex | PMI | Braak Stage |
Front NP count |
NFT counts |
ApoE alleles |
MMSE |
|---|---|---|---|---|---|---|---|---|---|
| Control | 1132 | 95 | F | 3.5 | 0 | 3.0 | 0 | 3/4 | 26 |
| Control | 1159 | 86 | F | 3.5 | 0 | 0.0 | 0 | 3/3 | 28 |
| Control | 1165 | 92 | M | 3.3 | 0 | 10.4 | 0 | 3/3 | 28 |
| Control | 1206 | 94 | F | 2.3 | 2 | 0.0 | 0.4 | 3/3 | 29 |
| Control | 1221 | 81 | M | 2.8 | 2 | 5.6 | 0 | 3/3 | 27 |
| AD | 1013 | 80 | M | 2.5 | 5 | 5.8 | 1 | ||
| AD | 1098 | 81 | F | 2.8 | 5 | 6.2 | 2 | 3/3 | 15 |
| AD | 1174 | 96 | M | 3.5 | 5 | 19.2 | 4 | 2/3 | 22 |
| AD | 1201 | 94 | M | 2.0 | 5 | 6.0 | 0.2 | 3/3 | 22 |
| AD | 1215 | 91 | F | 3.0 | 5 | 15.2 | 7.2 | 3/3 | 13 |
Patient information including reference number (Ref#), age, gender, Braak stage, postmortem interval (PMI), front neuritic plaque (NP) count, neurofibrillary tangle (NFT) count, ApoE genotype and Mini Mental State Examination (MMSE) score was provided by the UK ADC.